Temporal trends in the cost and use of first-line treatments for infantile epileptic spasms syndrome.
Iván Sánchez FernándezMarta Amengual-GualCristina Barcia AguilarAmanda RomeuTahir SheikhAlcy TorresJessica ChaoRinat JonasMarina Gaínza-LeinChellamani HariniLaurie DouglassPublished in: Epilepsia (2023)
The gap between the cost of ACTH and the cost of oral prednisolone or vigabatrin has widened markedly from 2006 to 2020, whereas the relative proportion of ACTH use has decreased.
Keyphrases